GLOPERBA
Live / Registered — Registered (as of 25 Mar 2025)
What this means for you
Registered since 25 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98273093
- Registration number
- 7740968
- Mark type
- Stylized text
- Filed
- 16 Nov 2023
- Published for opposition
- 30 Jul 2024
- Registered
- 25 Mar 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Colchicine based pharmaceutical preparations for the prevention of gout flares, recurrent pericarditis, familial Mediterranean fever (FMF), Behcet's disease and long-term atrial fibrillation; Colchicine based pharmaceutical preparations for the treatment of acute gout flares, acute pericarditis, on-going Behcet's disease, familial Mediterranean fever (FMF), and acute atrial fibrillation attack
Owner
- RxOMEG Therapeutics LLC, Woburn, MA, US
- RxOMEG Therapeutics LLC, Woburn, MA, US
- RxOMEG Therapeutics LLC, Woburn, MA, US
Prosecution history
- 25 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Oct 2024 — USE AMENDMENT FILED
- 24 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2024 — PUBLISHED FOR OPPOSITION
- 10 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jun 2024 — ASSIGNED TO EXAMINER
- 22 Dec 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED